Literature DB >> 33922205

Late Recurrence in Breast Cancer: To Run after the Oxen or to Try to Close the Barn?

Romano Demicheli1, Elia Biganzoli1.   

Abstract

The problem of late recurrence in breast cancer has recently gained attention and was also addressed in an international workshop held in Toronto (ON, Canada), in which several aspects of the question were examined. This Commentary offers a few considerations, which may be useful for the ongoing investigations. A few premises are discussed: (a) clinical recurrences, especially the late ones, imply periods of tumor dormancy; (b) a structured pattern of distant metastases appearance is detectable in both early and late follow-up times; (c) the current general paradigm underlying neoplastic treatments, i.e., that killing all cancer cells is the only way to control the disease, which is strictly sprouting from the somatic mutation theory, should be re-considered. Finally, a few research approaches are suggested.

Entities:  

Keywords:  cancer paradigms; recurrence dynamics; tumor dormancy

Year:  2021        PMID: 33922205     DOI: 10.3390/cancers13092026

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  53 in total

1.  Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery.

Authors:  Rona M MacKie; Robin Reid; Brian Junor
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

2.  Survival in breast cancer is familial.

Authors:  Kari Hemminki; Jianguang Ji; Asta Försti; Jan Sundquist; Per Lenner
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

3.  Tumor dormancy at bedside: A late awakening.

Authors:  Romano Demicheli; Christine Desmedt; Martine Piccart; Elia Biganzoli
Journal:  Breast       Date:  2019-03-02       Impact factor: 4.380

Review 4.  Mechanisms of tumor progression.

Authors:  P C Nowell
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

Review 5.  Perioperative events influence cancer recurrence risk after surgery.

Authors:  Jonathan G Hiller; Nicholas J Perry; George Poulogiannis; Bernhard Riedel; Erica K Sloan
Journal:  Nat Rev Clin Oncol       Date:  2017-12-28       Impact factor: 66.675

Review 6.  Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance.

Authors:  David Tarin
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

7.  Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.

Authors:  Per-Henrik Zahl; Peter C Gøtzsche; Jan Mæhlen
Journal:  Lancet Oncol       Date:  2011-10-11       Impact factor: 41.316

Review 8.  Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.

Authors:  Romano Demicheli; Michael W Retsky; William J M Hrushesky; Michael Baum
Journal:  Nat Clin Pract Oncol       Date:  2007-12

9.  TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.

Authors:  Neil A Bhowmick; Anna Chytil; David Plieth; Agnieszka E Gorska; Nancy Dumont; Scott Shappell; M Kay Washington; Eric G Neilson; Harold L Moses
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

Review 10.  Cancer as a changed tissue's way of life (when to treat, when to watch and when to think).

Authors:  Romano Demicheli; Dinah Faith T Quiton; Marco Fornili; William Jm Hrushesky
Journal:  Future Oncol       Date:  2016-02-01       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.